<DOC>
	<DOCNO>NCT01851512</DOCNO>
	<brief_summary>This single-blind , randomize , comparative , phase I study evaluate tolerability , safety pharmacokinetic characteristic human chorionic gonadotropin two recombinant hCG product name DA-3803 injection ovidrel liquid injection , healthy subject . The subject inject two injection 21day-interval time condition include vital sign , blood , clinical examination carefully observe .</brief_summary>
	<brief_title>A Study Evaluate Tolerability , Safety Pharmacokinetic Characteristics DA-3803</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<criteria>No medical history relate alimentary system , liver system , heart system , haematological disease Ideal body weight +/ 20 % acute disease within 28 day medical history might affect absorption , distribution , secretion , metabolism drug metrectomy surgery desexualization tubal ligation menopause pregnancy able use contraception drink alcohol 14 units/week smoker smoke 10 cigarette</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>